Public procurement notice: Contract Notice
Published: 2017-09-23
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33696100
Estimated value: 8120000 GBP
Submission deadline: 2017-10-24
Award criteria: The most economic tender

Technical requirements: This Framework Agreement is for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland.
The framework agreement will be awarded as a single supplier framework on a line by line basis for each product line.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of Sevelamer Hydrochloride 800 mg tablets, Sevelamer Carbonate 800 mg tablets, and Sevelamer Carbonate 2.4G powder for oral suspension to NHS Scotland.
Each product line will be treated as an individual Lot and be awarded on a line by line basis. Each Lot will be awarded as a single supplier framework agreement.
The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Framework Agreement is for the supply of the range of Erythropoietin Stimulating Agents to Health Boards across NHS Scotland.
Each product line will be treated as an individual Lot and be awarded on a line by line basis. Each Lot will be awarded as a single supplier framework agreement.
The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Framework Agreement is for the supply of the range of Erythropoietin Stimulating Agents supplied by homecare to patients across NHS Scotland.
Each product line will be treated as an individual Lot and be awarded on a line by line basis. Each Lot will be awarded as a single supplier framework agreement.
The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 8120000